Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:roflumilast
|
| gptkbp:approvalYear |
2022
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:form |
topical cream
|
| gptkbp:indication |
treatment of plaque psoriasis in patients 6 years and older
|
| gptkbp:manufacturer |
gptkb:Arcutis_Biotherapeutics
|
| gptkbp:mechanismOfAction |
PDE4 inhibitor
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
topical
|
| gptkbp:usedFor |
plaque psoriasis
|
| gptkbp:bfsParent |
gptkb:Arcutis_Biotherapeutics
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zoryve
|